Prognosis of patients with bladder tumors who received intra-arterial infusion chemotherapy in combination with angiotensin II

M. Saegusa, K. Kobashi, J. Ochi, M. Hara, T. Obama, J. Yoshimoto, Y. Matsumura, H. Ohmori, T. Johsen, Yasutomo Nasu, T. Hayashi, T. Akaeda, A. Nagai, T. Akagi

Research output: Contribution to journalArticle

Abstract

A combination of 70 mg/m2. cis-platinum, 40 mg/m2. doxorubicin or 40 mg/m2 tetrahydropyranyldoxorubicin instead of doxorubicin, and angiotensin II was infused into the bilateral internal iliac artery for the treatment of 31 patients with advanced bladder cancer (T2~T4). Of the 31 patients, 9 achieved CR and 16 achieved PR. We researched the prognosis of the patients, and discuss the usefulness of intra-arterial infusion chemotherapy (Al). Of 5 who achieved CR and underwent no successive therapy, 4 had recurrence and 2 died from cancer. This means Al is not sufficient by itself. Of 9 who achieved CR or PR and who finally underwent total cystectomy, 6 are disease free now. Therefore, we may expect Al to be useful as an adjuvant therapy prior to total cystectomy. The problems with this study were the follow-up duration and the number of patients. After we have continued to follow up patients for over 5 years, have increased the number of patients, and have compared the results with those cases who received no Al, a final conclusion should be considered.

Original languageEnglish
Pages (from-to)578-582
Number of pages5
JournalNishinihon Journal of Urology
Volume52
Issue number5
Publication statusPublished - 1990

Fingerprint

Intra Arterial Infusions
Combination Drug Therapy
Urinary Bladder Neoplasms
Angiotensin II
Cystectomy
Doxorubicin
Iliac Artery
Cisplatin
Therapeutics
Recurrence
Drug Therapy
Neoplasms

ASJC Scopus subject areas

  • Urology

Cite this

Saegusa, M., Kobashi, K., Ochi, J., Hara, M., Obama, T., Yoshimoto, J., ... Akagi, T. (1990). Prognosis of patients with bladder tumors who received intra-arterial infusion chemotherapy in combination with angiotensin II. Nishinihon Journal of Urology, 52(5), 578-582.

Prognosis of patients with bladder tumors who received intra-arterial infusion chemotherapy in combination with angiotensin II. / Saegusa, M.; Kobashi, K.; Ochi, J.; Hara, M.; Obama, T.; Yoshimoto, J.; Matsumura, Y.; Ohmori, H.; Johsen, T.; Nasu, Yasutomo; Hayashi, T.; Akaeda, T.; Nagai, A.; Akagi, T.

In: Nishinihon Journal of Urology, Vol. 52, No. 5, 1990, p. 578-582.

Research output: Contribution to journalArticle

Saegusa, M, Kobashi, K, Ochi, J, Hara, M, Obama, T, Yoshimoto, J, Matsumura, Y, Ohmori, H, Johsen, T, Nasu, Y, Hayashi, T, Akaeda, T, Nagai, A & Akagi, T 1990, 'Prognosis of patients with bladder tumors who received intra-arterial infusion chemotherapy in combination with angiotensin II', Nishinihon Journal of Urology, vol. 52, no. 5, pp. 578-582.
Saegusa, M. ; Kobashi, K. ; Ochi, J. ; Hara, M. ; Obama, T. ; Yoshimoto, J. ; Matsumura, Y. ; Ohmori, H. ; Johsen, T. ; Nasu, Yasutomo ; Hayashi, T. ; Akaeda, T. ; Nagai, A. ; Akagi, T. / Prognosis of patients with bladder tumors who received intra-arterial infusion chemotherapy in combination with angiotensin II. In: Nishinihon Journal of Urology. 1990 ; Vol. 52, No. 5. pp. 578-582.
@article{b940589c6b984d2cbe5820780e7e08ee,
title = "Prognosis of patients with bladder tumors who received intra-arterial infusion chemotherapy in combination with angiotensin II",
abstract = "A combination of 70 mg/m2. cis-platinum, 40 mg/m2. doxorubicin or 40 mg/m2 tetrahydropyranyldoxorubicin instead of doxorubicin, and angiotensin II was infused into the bilateral internal iliac artery for the treatment of 31 patients with advanced bladder cancer (T2~T4). Of the 31 patients, 9 achieved CR and 16 achieved PR. We researched the prognosis of the patients, and discuss the usefulness of intra-arterial infusion chemotherapy (Al). Of 5 who achieved CR and underwent no successive therapy, 4 had recurrence and 2 died from cancer. This means Al is not sufficient by itself. Of 9 who achieved CR or PR and who finally underwent total cystectomy, 6 are disease free now. Therefore, we may expect Al to be useful as an adjuvant therapy prior to total cystectomy. The problems with this study were the follow-up duration and the number of patients. After we have continued to follow up patients for over 5 years, have increased the number of patients, and have compared the results with those cases who received no Al, a final conclusion should be considered.",
author = "M. Saegusa and K. Kobashi and J. Ochi and M. Hara and T. Obama and J. Yoshimoto and Y. Matsumura and H. Ohmori and T. Johsen and Yasutomo Nasu and T. Hayashi and T. Akaeda and A. Nagai and T. Akagi",
year = "1990",
language = "English",
volume = "52",
pages = "578--582",
journal = "Nishinihon Journal of Urology",
issn = "0029-0726",
publisher = "Kyushu University, Faculty of Science",
number = "5",

}

TY - JOUR

T1 - Prognosis of patients with bladder tumors who received intra-arterial infusion chemotherapy in combination with angiotensin II

AU - Saegusa, M.

AU - Kobashi, K.

AU - Ochi, J.

AU - Hara, M.

AU - Obama, T.

AU - Yoshimoto, J.

AU - Matsumura, Y.

AU - Ohmori, H.

AU - Johsen, T.

AU - Nasu, Yasutomo

AU - Hayashi, T.

AU - Akaeda, T.

AU - Nagai, A.

AU - Akagi, T.

PY - 1990

Y1 - 1990

N2 - A combination of 70 mg/m2. cis-platinum, 40 mg/m2. doxorubicin or 40 mg/m2 tetrahydropyranyldoxorubicin instead of doxorubicin, and angiotensin II was infused into the bilateral internal iliac artery for the treatment of 31 patients with advanced bladder cancer (T2~T4). Of the 31 patients, 9 achieved CR and 16 achieved PR. We researched the prognosis of the patients, and discuss the usefulness of intra-arterial infusion chemotherapy (Al). Of 5 who achieved CR and underwent no successive therapy, 4 had recurrence and 2 died from cancer. This means Al is not sufficient by itself. Of 9 who achieved CR or PR and who finally underwent total cystectomy, 6 are disease free now. Therefore, we may expect Al to be useful as an adjuvant therapy prior to total cystectomy. The problems with this study were the follow-up duration and the number of patients. After we have continued to follow up patients for over 5 years, have increased the number of patients, and have compared the results with those cases who received no Al, a final conclusion should be considered.

AB - A combination of 70 mg/m2. cis-platinum, 40 mg/m2. doxorubicin or 40 mg/m2 tetrahydropyranyldoxorubicin instead of doxorubicin, and angiotensin II was infused into the bilateral internal iliac artery for the treatment of 31 patients with advanced bladder cancer (T2~T4). Of the 31 patients, 9 achieved CR and 16 achieved PR. We researched the prognosis of the patients, and discuss the usefulness of intra-arterial infusion chemotherapy (Al). Of 5 who achieved CR and underwent no successive therapy, 4 had recurrence and 2 died from cancer. This means Al is not sufficient by itself. Of 9 who achieved CR or PR and who finally underwent total cystectomy, 6 are disease free now. Therefore, we may expect Al to be useful as an adjuvant therapy prior to total cystectomy. The problems with this study were the follow-up duration and the number of patients. After we have continued to follow up patients for over 5 years, have increased the number of patients, and have compared the results with those cases who received no Al, a final conclusion should be considered.

UR - http://www.scopus.com/inward/record.url?scp=0025109415&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025109415&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0025109415

VL - 52

SP - 578

EP - 582

JO - Nishinihon Journal of Urology

JF - Nishinihon Journal of Urology

SN - 0029-0726

IS - 5

ER -